Anticorps Monoclonal anti-HIF2α/EPAS1
HIF2α/EPAS1 Monoclonal Antibody for WB, IHC, Indirect ELISA
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain
Applications
WB, IHC, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
2F6B12
N° de cat : 66731-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
66731-1-PBS cible HIF2α/EPAS1 dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Mouse / IgG2a |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | HIF2α/EPAS1 Protéine recombinante Ag24886 |
| Nom complet | endothelial PAS domain protein 1 |
| Masse moléculaire calculée | 96 kDa |
| Poids moléculaire observé | 120 kDa |
| Numéro d’acquisition GenBank | BC051338 |
| Symbole du gène | HIF2α |
| Identification du gène (NCBI) | 2034 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Endothelial PAS domain-containing protein 1 (EPAS1), also known as Hypoxia-inducible factor 2-alpha (HIF2-alpha,HIF2A), is a transcription factor involved in the induction of oxygen regulated genes. Binds to core DNA sequence 5'-[AG]CGTG-3' within the hypoxia response element (HRE) of target gene promoters. Regulates the vascular endothelial growth factor (VEGF) expression and seems to be implicated in the development of blood vessels and the tubular system of lung. May also play a role in the formation of the endothelium that gives rise to the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase expression. Activation seems to require recruitment of transcriptional coactivators such as CREBPB and probably EP300. Interaction with redox regulatory protein APEX seems to activate CTAD. EPAS1 is expressed in most tissues, with highest levels in placenta, lung and heart. Selectively expressed in endothelial cells.







